Validation of a 3-Dimensional Human Liver Microtissue Model for Long-term Hepatotoxicity Studies
Poster Oct 08, 2014
Brad Larson1, Stewart Hunt2, Timothy Moeller3, Diana Long4, and Peter Banks1
Multiple in vitro animal models have been used to determine the varied mechanisms of action (MOA) of NSAID-related hepatotoxicity. Studies using rat liver mitochondria and freshly isolated rat hepatocytes demonstrated that diphenylamine, a common NSAID structure, uncoupled oxidative phosphorylation, and decreased hepatic ATP content (Masubuchi et al., 2000). Mitochondrial permeability transition (MPT) has also been shown to be important in diclofenac-induced liver injury, as well as the role that oxidative stress plays in MPT induction (Gómez-Lechón et al., 2003). Finally, according to work done by Schmitz et al., 1992, cytochrome P450 (CYP)-related metabolic activation of the drug, and the formation of reactive metabolites is also related to diclofenac hepatotoxicity.
The combined hepatotoxic effects of these mechanisms usually occurs within weeks of therapy commencement. This emphasizes the fact that in vitro safety testing should incorporate dosing experiments that analyze the effects of a potential drug for periods reaching out to 7-14 days or longer. However, primary hepatocytes cultured in a twodimensional (2D) manner on the bottom of a microplate, standard practice for in vitro liver toxicity testing, have been shown to undergo rapid loss of differentiated function and metabolic capacity (Cheng et al., 2008), and have less complex inter-cellular and cell-matrix interactions compared to in vivo. What is required is a cell culture model where cells retain viability and function long-term, by creating a favorable environment for these interactions to reform.
Here we evaluate the suitability of 3D human liver microtissues for use in longterm toxicity studies. Primary human hepatocytes are reaggregated into functional microtissues by hanging drop technology. The microtissues demonstrate in vivo like cellcell and cell-matrix interactions and retained viability over weeks. A panel of assays was run to assess cell health and the different MOA exhibited by diclofenac using the 3D liver microtissues, in addition to primary hepatocytes cultured in 2D. Quantification of the various luminescent and fluorescent emissions via microplate reading and imaging was be carried out by a novel cell imaging multi-mode reader.
Exploiting Polypharmacology in Precision Oncology: Identification of Differential Kinase Off-targets Among Clinical PARP InhibitorsPoster
Can we use computational methods to identify previously unknown off-targets of PARP inhibitors that can explain their observed differences?READ MORE
LC-SWATH/MS Metabolomics Platform with Hyphenation of Extraction for the Analysis of Polar and Non-polar Metabolites in Biological SamplesPoster
Automated robotic sample preparation with hyphenated dual LC-SWATH/MS analysis for lipids and polar metabolites.
Bioluminescent Assay for GTPases Allows Measurement of GTPase, GAP and GEF ActivitiesPoster
We have developed a homogenous bioluminescent assay (GTPase-Glo) system to analyze these proteins in a simple, convenient “add-mix-read” format.READ MORE